KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amkor Technology (AMKR) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for Amkor Technology (AMKR) over the last 17 years, with Q3 2025 value amounting to $1.5 billion.

  • Amkor Technology's Cash & Equivalents rose 5593.72% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 5593.72%. This contributed to the annual value of $1.1 billion for FY2024, which is 122.65% up from last year.
  • Amkor Technology's Revenue - Interest and Investment Income amounted to $428.2 million in Q1 2010, which was up 10977.79% from $383.2 million recorded in Q4 2009.
  • Amkor Technology's Cash & Equivalents' 5-year high stood at $1.5 billion during Q2 2025, with a 5-year trough of $545.6 million in Q3 2021.
  • In the last 5 years, Amkor Technology's Cash & Equivalents had a median value of $909.8 million in 2023 and averaged $940.0 million.
  • Examining YoY changes over the last 5 years, Amkor Technology's Revenue - Interest and Investment Income showed a top increase of 10977.79% in 2010 and a maximum decrease of 10977.79% in 2010.
  • Over the past 2 years, Amkor Technology's Revenue - Interest and Investment Income (Quarter) stood at $383.2 million in 2009, then increased by 11.75% to $428.2 million in 2010.
  • Its Cash & Equivalents was $1.5 billion in Q3 2025, compared to $1.5 billion in Q2 2025 and $1.1 billion in Q1 2025.